The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 20, 2010

Filed:

Sep. 28, 2007
Applicants:

Martin Kean Chong NG, Mosman, New South Wales, AU;

Anthony Steven Weiss, NSW 2031, Randwick, AU;

Steven Garry Wise, NSW 2213, New South Wales, Sydney, AU;

Inventors:

Martin Kean Chong Ng, Mosman, New South Wales, AU;

Anthony Steven Weiss, NSW 2031, Randwick, AU;

Steven Garry Wise, NSW 2213, New South Wales, Sydney, AU;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Biocompatible materials suitable for use in vascular applications have been engineered, combining human recombinant tropoelastin with other synthetic or natural biomaterials to form protoelastin. The materials can be in the form of elastin films on metal, bone, ceramic or polymer substrates, laminates of alternating polymer and elastin, blends of polymer and elastin, or elastin crosslinked with or tethered to polymer. The flexibility in engineering and design makes protoelastin biomaterials suited not only to the production of conduits but any number of other vascular applications that require blood contacting surfaces. Tropoelastin and the subsequently engineered biomaterial protoelastin provide the opportunity to satisfy a large unmet need for a biocompatible material adaptable enough to meet a range of diverse vascular uses. These are mechanically stable, elastic, strong and biocompatible (i.e., not thrombogenic and promoting adhesion of cells, especially human endothelial cells.


Find Patent Forward Citations

Loading…